Interaction between lysolecithin and platelets and its relationship to disease.
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood; D001792:Blood Platelets / Q000502:physiology*; D002318:Cardiovascular Diseases / Q000097:blood*; D006801:Humans; D006951:Hyperlipoproteinemias / Q000097:blood; D008103:Liver Cirrhosis / Q000097:blood; D008244:Lysophosphatidylcholines / Q000097:blood / Q000494:pharmacology*; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000097:blood; D010973:Platelet Adhesiveness / Q000187:drug effects; D010974:Platelet Aggregation / Q000187:drug effects; D011817:Rabbits; D012310:Ristocetin / Q000494:pharmacology; D013927:Thrombosis / Q000097:blood; D014841:von Willebrand Factor / Q000502:physiology
D008244:Lysophosphatidylcholines; D014841:von Willebrand Factor; D012310:Ristocetin; D007862:Phosphatidylcholine-Sterol O-Acyltransferase